TipRanks
Go Ultimate55% OFF

Atara Biotherapeutics (AT20) Cash flow

Atara Biotherapeutics Cash Flow

DE:AT20's free cash flow for Q2 2026 was $-3.34M. For the 2026 fiscal year, DE:AT20's free cash flow was increased by $0.00 and operating cash flow was $-3.34M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -50.94M$ -68.72M$ -192.98M$ -270.43M$ -220.52M
$ 18.15M$ 8.62M$ 123.87M$ 202.96M$ 22.26M
$ 16.10M$ 59.28M$ 2.01M$ 53.08M$ 103.94M
$ 8.48M$ 25.18M$ 25.99M$ 93.09M$ 107.48M
$ -50.94M$ -68.96M$ -194.20M$ -274.62M$ -231.10M

Currency in USD

Atara Biotherapeutics Cash Flow

-400M-200M0200M400M600M201720182019202020212022202320242025OperatingInvestingFinancing